Skip to content
Search

Latest Stories

Cases of norovirus in England almost tripled last week

Norovirus Surge Sparks Concerns
Norovirus

The number of norovirus, flu and RSV infections are likely to increase further this week due to cold weather, warns Professor Sir Stephen Powis

Winter pressures are already mounting on NHS staff ahead of December, with high levels of demand in hospitals due to a significant increase in cases of norovirus infection.


Norovirus is a highly contagious virus which spreads through contaminated food, water or surfaces and causes vomiting and diarrhea.

New NHS figures revealed that an average of 351 people were hospitalised with diarrhoea and vomiting symptoms every day last week in England, almost triple the number during the same period last winter, which was 126.

The number of children in hospital with the virus was also higher last week (13) compared the same week last year (an average of just three), according to the weekly winter update published by the health service on 30 November.

NHS teams expanded hospital capacity to 100,701 last week from 99,243 last year, an increase of almost 1,500 beds.

Hospitalisation rates remain high among adults, with adult bed occupancy reported at 95.3 per cent.

There were over 1,200 more patients in adult general and acute beds last week compared to the end of November 2022 (90,144 vs 88,902).

Furthermore, 153 flu patients were admitted in hospitals each day last week with seven critical cases on a daily basis, and an additional 131 children were in hospital each day with RSV.

Meanwhile, NHS national medical director, Professor Sir Stephen Powis, has warned that the impact of norovirus, flu and RSV infections on hospital capacity are “likely to be exacerbated by this week’s cold weather, and the demand on hospitals and staff is high is “likely to grow considerably before Christmas.”

Therefore, he has urged the public to play their part by “using services in the usual way – by calling 999 in an emergency and using NHS 111 for other health conditions – and by getting their Covid and flu jabs if eligible.”

Innovative measures helping reduce care delays

The weekly winter update showed positive outcomes of innovative measures taken up reduce for winter pressures and the hard work of NHS staff.

Last week, the NHS staff managed to reduce time lost to ambulance handover delays by more than a fifth as compared to the same week last year (from 24,372 hours to 18,987), despite higher number of patients arriving via ambulance this time (89,506 vs 77,054).

The NHS 111 service received 419,676 calls last week compared to 423,969 the same week last year, but 67 per cent of calls were answered within a minute, almost double than last year, thanks to the increase in the number of call handlers.

However, challenges still remain in discharging patients who no longer need to be in hospital into settings such as social and community care.

As shown by the NHS data, an average of 12,654 beds each day last week were occupied by patients who were ready for discharge, taking up one in seven of all occupied adult general and acute beds (90,144).

More than 46,000 staff per day were off work sick last week, of which 1,715 absences were due to Covid-19, the new data revealed.

Robust NHS plans set out for this winter, include the nationwide rollout of care ‘traffic control’ centres, extra ambulances and beds, rapid expansion of virtual ward programme, and treating more people at home and in the community where appropriate.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less